Zhejiang Raygene Pharmaceuticals Co., Ltd

This phase I/II clinical trial aims to determine the efficacy and safety of TATE compared to TACE in patients with intermediate-stage HCC. The results will provide valuable insights into the potential benefits of TATE as a novel treatment option for HCC.

评价接受替拉扎明经肝动脉注射后再行肝动脉栓塞术治疗中期原发性肝细胞癌是否优于传统的肝动脉化疗栓塞术，具体评价指标为患者接受 TATE/TACE 治疗后的无进展生存期（PFS）

A single-arm, multicenter, Phase IIA study of Intra-arterial Administration of Tirapazamine followed by Transarterial Embolization (TATE) and KN046 (recombinant humanized anti-PD-L1/CTLA-4 bispecific single-domain antibody Fc fusion protein injection) in patients with liver metastases from colorectal cancer.